Description

TESAMORELIN – ADVANCED GROWTH HORMONE & ABDOMINAL FAT SUPPORT

Elevate Wellness Hub’s Tesamorelin is a growth hormone-releasing factor (GHRF) analogue that stimulates the body’s natural growth hormone pathway. It is clinically approved in the United States for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.

KEY BENEFITS

• Supports growth hormone signalling

• Supports reduction of excess abdominal fat in its approved indication

• Supports research into body-composition pathways

• Increases growth hormone and IGF-1 activity

• Supports research into metabolic and adipose-tissue biology

• Investigated for its effects on visceral adipose tissue

WHO MAY BENEFIT?

Tesamorelin is specifically indicated for adults with HIV-associated lipodystrophy who have excess abdominal fat. It is not indicated as a general weight-loss medication, and suitability should be determined by a qualified healthcare professional.

Always use under the guidance of a qualified healthcare professional.

HOW IT MAY HELP

• Tesamorelin acts as an analogue of growth hormone-releasing factor

• Stimulates the pituitary gland to increase growth hormone secretion

• Increased growth hormone activity raises circulating IGF-1 levels

• Clinical studies have demonstrated reductions in excess abdominal/visceral adipose tissue in the approved patient population

• Its effects on body composition are being studied in relation to growth-hormone signalling and adipose-tissue metabolism

Tesamorelin’s approved indication is specifically related to HIV-associated lipodystrophy rather than general weight management.

POSSIBLE SIDE EFFECTS

Common or clinically important adverse effects may include:

• Injection-site redness, itching, pain, irritation, or bruising

• Joint pain

• Muscle pain

• Peripheral swelling or fluid retention

• Numbness or tingling

• Carpal tunnel syndrome

• Increased blood glucose or impaired glucose tolerance

• Increased IGF-1 levels

• Hypersensitivity or allergic reactions

Tesamorelin may increase IGF-1 and can cause fluid retention and glucose intolerance or diabetes; these effects require appropriate clinical monitoring.

NOT SUITABLE FOR

• Pregnancy

• Individuals with active malignancy

• Individuals with disruption of the hypothalamic-pituitary axis

• Anyone with a known hypersensitivity to tesamorelin or its ingredients

• Children unless specifically directed by an appropriate specialist

• Individuals with uncontrolled glucose abnormalities without appropriate medical assessment

• Anyone with a history of malignancy without appropriate specialist evaluation

The prescribing information specifically contraindicates tesamorelin in pregnancy, active malignancy, disruption of the hypothalamic-pituitary axis, and known hypersensitivity.

IMPORTANT DISCLAIMER

Tesamorelin is a prescription growth hormone-releasing factor analogue with an established FDA-approved indication for reducing excess abdominal fat in adults with HIV-associated lipodystrophy.

It should not be marketed as a general weight-loss, anti-aging, muscle-building, or wellness treatment. Long-term cardiovascular safety has not been established, and treatment can increase IGF-1 and affect glucose regulation. Appropriate medical assessment and monitoring are required.

Elevate Wellness Hub does not represent Tesamorelin as a substitute for appropriate medical care. Any use should comply with applicable laws, prescribing requirements, and qualified healthcare-professional supervision.

The 20 mg listed by Elevate Wellness Hub refers to the product strength and is not a dosing recommendation.

It’s not just about feeling better, it’s about elevating your quality of life.

ELEVATE WELLNESS HUB – PEPTIDE WELLNESS. SCIENCE BACKED. RESULTS DRIVEN. YOU ELEVATED.